US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NovaBridge Biosciences

1.59

-0.1000-5.92%

Post-market: 1.620.0300+1.89%19:51 EDT

Volume:252.83K

Turnover:407.19K

Market Cap:184.44M

PE:-2.41

High:1.71

Open:1.70

Low:1.58

Close:1.69

52wk High:6.79

52wk Low:1.46

Shares:116.00M

Float Shares:64.56M

Volume Ratio:1.58

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6591

EPS(LYR):-0.9225

ROE:-59.10%

ROA:-34.98%

PB:0.92

PE(LYR):-1.72

Loading ...

Overview Company News Filings

NovaBridge Biosciences Director Martin William Dewhurst Files Initial Beneficial Ownership Statement

NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive

Novabridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

THOMSON REUTERS

Press Release: NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

NovaBridge EVP Clinical Development Xu Cong Claire Sells 3,282 Shares for $0.79 Each

NovaBridge Biosciences CEO to Present at Cantor Global Healthcare Conference

NovaBridge Biosciences Price Target Maintained with a $9.00/Share by HC Wainwright & Co.

NovaBridge Net Loss Widens to $37.9 Million in FY26 First Half; R&D Expenses More than Doubled to $14.3 Million

NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate

Benzinga Earnings

Novabridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution

THOMSON REUTERS

NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview

NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview

NovaBridge Biosciences Schedules Webcast for First-Half 2026 Results, Corporate Update

Novabridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

THOMSON REUTERS

Village Farms International And 2 Other Penny Stocks Worth Watching

Simply Wall St.

Press Release: Novabridge Biosciences to Hold Annual General Meeting on September 8, 2026

Novabridge Biosciences Launches 2026 Omnibus Share Incentive Plan with 11,960,000 Shares Authorized

Poland’s central bank is buying the dip as gold's biggest buyers aren't backing down

Novabridge Biosciences CEO, Director Srishti Gupta Files Initial Beneficial Ownership Statement

Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/NBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","market":"US","secType":"STK","nameCN":"NovaBridge Biosciences","latestPrice":1.59,"timestamp":1789156800000,"preClose":1.69,"halted":0,"volume":252833,"hourTrading":{"tag":"盘后","latestPrice":1.62,"preClose":1.59,"latestTime":"19:51 EDT","volume":216,"amount":349.42,"timestamp":1789170664750,"change":0.03,"changeRate":0.018868,"amplitude":0.018868},"delay":0,"changeRate":-0.059171597633136015,"floatShares":64563600,"shares":115999216,"eps":-0.6591,"marketStatus":"Market Closed","change":-0.1,"latestTime":"09-11 16:00:00 EDT","open":1.7,"high":1.71,"low":1.58,"amount":407188.6083986,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.6591,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":1.69,"preHourTrading":{"tag":"盘前","latestPrice":1.6997,"preClose":1.69,"latestTime":"09:12 EDT","volume":1157,"amount":1945.8296416,"timestamp":1789132322472,"change":0.0097,"changeRate":0.00574,"amplitude":0.017751},"postHourTrading":{"tag":"盘后","latestPrice":1.62,"preClose":1.59,"latestTime":"19:51 EDT","volume":216,"amount":349.42,"timestamp":1789170664750,"change":0.03,"changeRate":0.018868,"amplitude":0.018868},"volumeRatio":1.575022456061781,"impliedVol":0.9503,"impliedVolPercentile":0.4424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","floatShares":64563600,"roa":"-34.98%","roe":"-59.10%","lyrEps":-0.922468,"volumeRatio":1.575022456061781,"shares":115999216,"dividePrice":0,"high":1.71,"amplitude":0.076923,"preClose":1.69,"low":1.58,"week52Low":1.46,"pbRate":"0.92","week52High":6.79,"institutionHeld":0,"latestPrice":1.59,"eps":-0.6591,"divideRate":0,"volume":252833,"delay":0,"ttmEps":-0.6591,"open":1.7,"prevYearClose":3.98,"prevWeekClose":1.8,"prevMonthClose":1.82,"prevQuarterClose":1.95,"fiveDayClose":1.8,"twentyDayClose":1.9,"sixtyDayClose":1.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBP\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"NBP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787212800000,"name":null,"time":"Pre-MKt","dateTimestamp":1787198400000,"actualEps":null},{"market":"US","date":"2026-04-07","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1775534400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"NBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-15","symbol":"NBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-04-03","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1743652800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1759550400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBP","date":"2026-09-11","current":-2.412381,"percent":1,"low":-20.276437,"twenty":-14.425612,"median":-3.53465,"eighty":-2.290977,"high":-1.667648,"avg":-8.236858,"sd":6.09552,"marketCap":196038675},"quantilePoints":[{"date":"2025-10-31","current":-13.114792,"twenty":-13.114792,"median":-13.114792,"eighty":-13.114792,"marketCap":524460541},{"date":"2025-11-07","current":-12.077138,"twenty":-13.547148,"median":-12.71126,"eighty":-12.278904,"marketCap":482964762},{"date":"2025-11-14","current":-12.019491,"twenty":-13.114792,"median":-12.278904,"eighty":-12.077138,"marketCap":480659441},{"date":"2025-11-21","current":-12.077138,"twenty":-13.085968,"median":-12.293316,"eighty":-12.077138,"marketCap":482964762},{"date":"2025-11-28","current":-11.068308,"twenty":-13.06291,"median":-12.192433,"eighty":-11.881137,"marketCap":442621643},{"date":"2025-12-05","current":-11.500664,"twenty":-12.688201,"median":-12.077138,"eighty":-11.212426,"marketCap":459911551},{"date":"2025-12-12","current":-11.298898,"twenty":-12.411494,"median":-12.033903,"eighty":-11.287368,"marketCap":451842927},{"date":"2025-12-19","current":-17.342266,"twenty":-12.688201,"median":-12.048315,"eighty":-11.460311,"marketCap":456552482},{"date":"2025-12-26","current":-20.276437,"twenty":-13.287734,"median":-12.077138,"eighty":-11.500664,"marketCap":533797473},{"date":"2026-01-02","current":-17.429853,"twenty":-17.342266,"median":-12.163609,"eighty":-11.512194,"marketCap":458858303},{"date":"2026-01-09","current":-16.597774,"twenty":-17.482405,"median":-12.235668,"eighty":-11.541017,"marketCap":436953007},{"date":"2026-01-16","current":-16.028458,"twenty":-17.394818,"median":-12.365376,"eighty":-11.569841,"marketCap":421965173},{"date":"2026-01-23","current":-17.03571,"twenty":-17.342266,"median":-13.057145,"eighty":-11.587135,"marketCap":448482110},{"date":"2026-01-30","current":-16.116045,"twenty":-17.3773,"median":-13.33097,"eighty":-11.615959,"marketCap":424270994},{"date":"2026-02-06","current":-14.583269,"twenty":-17.342266,"median":-14.495682,"eighty":-11.742783,"marketCap":383919133},{"date":"2026-02-13","current":-14.189126,"twenty":-17.307231,"median":-14.71465,"eighty":-11.823489,"marketCap":373542940},{"date":"2026-02-20","current":-14.539475,"twenty":-17.167091,"median":-14.517578,"eighty":-11.961843,"marketCap":382766222},{"date":"2026-02-27","current":-14.364301,"twenty":-17.03571,"median":-14.408094,"eighty":-12.019491,"marketCap":378154581},{"date":"2026-03-06","current":-15.94087,"twenty":-17.03571,"median":-14.386197,"eighty":-12.048315,"marketCap":419659352},{"date":"2026-03-13","current":-12.875318,"twenty":-16.991917,"median":-14.364301,"eighty":-12.077138,"marketCap":338955631},{"date":"2026-03-20","current":-11.780478,"twenty":-16.948123,"median":-14.316021,"eighty":-12.077138,"marketCap":310132873},{"date":"2026-03-27","current":-11.167368,"twenty":-16.597774,"median":-14.189126,"eighty":-11.788901,"marketCap":293992129},{"date":"2026-04-02","current":-10.773226,"twenty":-16.597774,"median":-14.101539,"eighty":-11.587135,"marketCap":283615936},{"date":"2026-04-10","current":-3.171352,"twenty":-16.387565,"median":-14.057746,"eighty":-11.527134,"marketCap":280157205},{"date":"2026-04-17","current":-3.495376,"twenty":-16.299978,"median":-13.61981,"eighty":-11.287368,"marketCap":308781505},{"date":"2026-04-24","current":-3.23355,"twenty":-16.221149,"median":-13.10038,"eighty":-11.118286,"marketCap":285651804},{"date":"2026-05-01","current":-3.23355,"twenty":-16.203632,"median":-12.875318,"eighty":-11.061844,"marketCap":285651804},{"date":"2026-05-08","current":-2.906268,"twenty":-16.133562,"median":-12.604261,"eighty":-10.634902,"marketCap":256739678},{"date":"2026-05-15","current":-2.513529,"twenty":-16.045975,"median":-12.365376,"eighty":-3.526795,"marketCap":222045127},{"date":"2026-05-22","current":-2.330251,"twenty":-15.993423,"median":-12.293316,"eighty":-3.374936,"marketCap":205854337},{"date":"2026-05-29","current":-2.448072,"twenty":-15.958388,"median":-12.192433,"eighty":-3.235384,"marketCap":216262702},{"date":"2026-06-05","current":-2.356433,"twenty":-15.651833,"median":-12.134786,"eighty":-3.190946,"marketCap":208167307},{"date":"2026-06-12","current":-1.92442,"twenty":-15.393451,"median":-12.062727,"eighty":-3.136675,"marketCap":170003300},{"date":"2026-06-18","current":-2.055333,"twenty":-15.340898,"median":-11.990667,"eighty":-3.100019,"marketCap":181568151},{"date":"2026-06-26","current":-2.094607,"twenty":-15.292725,"median":-11.780478,"eighty":-2.890558,"marketCap":185037606},{"date":"2026-07-02","current":-2.605168,"twenty":-15.231414,"median":-11.587135,"eighty":-2.686334,"marketCap":230140522},{"date":"2026-07-10","current":-2.434981,"twenty":-15.178862,"median":-11.559911,"eighty":-2.610404,"marketCap":215106217},{"date":"2026-07-17","current":-2.343342,"twenty":-15.091275,"median":-11.517717,"eighty":-2.516147,"marketCap":207010822},{"date":"2026-07-24","current":-2.317159,"twenty":-15.012446,"median":-11.399781,"eighty":-2.437599,"marketCap":204697852},{"date":"2026-07-31","current":-2.146972,"twenty":-14.977411,"median":-11.226206,"eighty":-2.42189,"marketCap":189663546},{"date":"2026-08-07","current":-2.22552,"twenty":-14.977411,"median":-11.123574,"eighty":-2.356433,"marketCap":196602456},{"date":"2026-08-14","current":-2.487346,"twenty":-14.84603,"median":-11.068308,"eighty":-2.356433,"marketCap":219732157},{"date":"2026-08-21","current":-1.87904,"twenty":-14.583269,"median":-11.035987,"eighty":-2.356433,"marketCap":220888642},{"date":"2026-08-28","current":-1.865003,"twenty":-14.539475,"median":-10.707535,"eighty":-2.330251,"marketCap":219238518},{"date":"2026-09-04","current":-1.776193,"twenty":-14.495682,"median":-10.598051,"eighty":-2.317159,"marketCap":208798588},{"date":"2026-09-11","current":-1.667648,"twenty":-14.425612,"median":-3.53465,"eighty":-2.290977,"marketCap":196038675}],"updateTime":1789284246491},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666515198","title":"NovaBridge Biosciences Director Martin William Dewhurst Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515198?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:23","pubTimestamp":1789071780,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences director Martin William Dewhurst files initial beneficial ownership statementNovaBridge Biosciences director Martin William Dewhurst filed an initial Form 3 on Sept. 10 covering","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9C73C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327109","title":"NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327109","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327109?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:28","pubTimestamp":1788866923,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NovaBridge Biosciences ( ($NBP) ). NovaBridge Biosciences reported on September 8, 2026, that it has appointed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","XBI","BK4585","BK4137","LU0029874061.USD","BK4588","LU0128526141.USD","LABU","HCSG","BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322598","title":"Novabridge Appoints Martin Dewhurst to Board of Directors as an Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322598","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322598?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA2YPVXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TTRX","BK4139","NBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332298","title":"Press Release: NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332298","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332298?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"-- Martin Dewhurst appointed as independent director and member of the Audit. -- Veteran healthcare executive brings more than 30 years of leadership,","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861756","title":"NovaBridge EVP Clinical Development Xu Cong Claire Sells 3,282 Shares for $0.79 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861756","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861756?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:01","pubTimestamp":1788300077,"startTime":"0","endTime":"0","summary":"NovaBridge EVP Clinical Development Xu Cong Claire sells 3,282 shares for $0.79 eachNovaBridge Biosciences EVP, Clinical Development Xu Cong Claire reported an increase in ordinary share holdings tied","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL2FL6PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NovaBridge EVP Clinical Development Xu Cong Claire Sells 3,282 Shares for $0.79 Each","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709953","title":"NovaBridge Biosciences CEO to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662709953?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:02","pubTimestamp":1787828531,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences CEO to present at Cantor Global Healthcare ConferenceNovaBridge Biosciences will present at the Cantor 2026 Global Healthcare Conference on Sept. 10, 2026 at 1:00 p.m. ET.CEO Sr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL90NkPR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","NDAQ","IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","NBP","BK4112","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BCDF","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","IE00BQXX3C00.GBP","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","SG9999014013.SGD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661361822","title":"NovaBridge Biosciences Price Target Maintained with a $9.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661361822","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661361822?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:47","pubTimestamp":1787244420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBP/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286568","title":"NovaBridge Net Loss Widens to $37.9 Million in FY26 First Half; R&D Expenses More than Doubled to $14.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286568","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286568?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:01","pubTimestamp":1787223706,"startTime":"0","endTime":"0","summary":"NovaBridge net loss widens to $37.9 million in FY26 first half; R&D expenses more than doubled to $14.3 millionNovaBridge posted a GAAP net loss of USD 37.9 million; loss per share widened to USD 0.14","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7rbjbk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","NBP","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BGHQF748.EUR","BCDF","BK4112","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","BK4139","LU2095319765.USD","BK4585","NDAQ","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286580","title":"NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286580","media":"Benzinga Earnings","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286580?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:01","pubTimestamp":1787223664,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences (NASDAQ:NBP) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.14) by 135.71 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61324048/novabridge-biosciences-h1-eps-0-33-misses-0-14-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286356","title":"Novabridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286356?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA9BZ5YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446768","title":"NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446768","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446768?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:44","pubTimestamp":1787057063,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences <NBP.OQ> expected to post a loss of13cents a share - Earnings PreviewNovaBridge BiosciencesNBP.OQNBP.Ois expected to  show no change in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL8N44F0P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414452","title":"NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414452","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414452?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:08","pubTimestamp":1786712885,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences <NBP.OQ> expected to post a loss of13cents a share - Earnings PreviewNovaBridge BiosciencesNBP.OQNBP.Ois expected to  show no change in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160107","title":"NovaBridge Biosciences Schedules Webcast for First-Half 2026 Results, Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160107?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:00","pubTimestamp":1786654857,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences schedules webcast for first-half 2026 results, corporate updateNovaBridge schedules a webcast on Aug. 20, 2026 to report first-half 2026 financial results and give a corporate u","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbFBzTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4112","LU0314104364.USD","SG9999014021.USD","BK4585","IE00B64PRP62.GBP","BCDF","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","LU2095319765.USD","IE00BGHQF748.EUR","BK4588","NDAQ","IE00BN0W2W23.USD","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160123","title":"Novabridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160123?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:00","pubTimestamp":1786654842,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA9LM0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658582949","title":"Village Farms International And 2 Other Penny Stocks Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2658582949","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658582949?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:05","pubTimestamp":1786381509,"startTime":"0","endTime":"0","summary":"The market has shown robust performance, with a 2.7% increase over the last week and a 21% rise in the past year, while earnings are expected to grow by 17% annually. In light of these conditions, investors may find value in exploring penny stocks—an older term that still signifies potential within smaller or emerging companies. By focusing on those with solid financials and growth potential, investors can uncover opportunities for both stability and upside in this unique segment of the market.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/news/village-farms-international-and-2-other-penny-stocks-worth-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/news/village-farms-international-and-2-other-penny-stocks-worth-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","NBP","BK4189","VFF","QTRX","BK4139","MJ","YOLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654694037","title":"Press Release: Novabridge Biosciences to Hold Annual General Meeting on September 8, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654694037","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654694037?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:00","pubTimestamp":1784926800,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (\"NovaBridge\" or the \"Company\"), a clinical-stage biopharmaceutical company advancing innovative medicines for ar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652044324","title":"Novabridge Biosciences Launches 2026 Omnibus Share Incentive Plan with 11,960,000 Shares Authorized","url":"https://stock-news.laohu8.com/highlight/detail?id=2652044324","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652044324?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:05","pubTimestamp":1784282711,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences launches 2026 omnibus share incentive plan with 11,960,000 shares authorizedNovaBridge Biosciences adopted a 2026 Omnibus Share Incentive Plan effective July 13, 2026, replacing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL1tMdJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650134777","title":"Poland’s central bank is buying the dip as gold's biggest buyers aren't backing down","url":"https://stock-news.laohu8.com/highlight/detail?id=2650134777","media":"Kitco","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650134777?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:05","pubTimestamp":1783677900,"startTime":"0","endTime":"0","summary":"(Kitco News) - While speculators and retail investors have been liquidating their gold holdings, one major pillar of support remains firmly in place, with central banks viewing the current price actio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"kitco_highlight","url":"https://www.kitco.com/news/article/2026-07-10/polands-central-bank-buying-dip-golds-biggest-buyers-arent-backing-down","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.kitco.com/news/article/2026-07-10/polands-central-bank-buying-dip-golds-biggest-buyers-arent-backing-down","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kitco_highlight","symbols":["UYM","IAU","DUST","DGP","IAUM","IGLD","DULL","GDXJ","GBUG","GOAU","SGDM","BEGS","FGDL","GDXD","IAUI","PHYS","UGL","OUNZ","PICK","DZZ","1OZmain","GLL","SGOL","USG","DBC","AAAU","PPI","JNUG","BK4588","DGZ","GDXY","GLD","BGLD","GLDY","KGLD","SHNY","XME","GLTR","NBP","RING","YGLD","GDXU","BTGD","BK4504","CEF","GLDM","JDST","GDX","BAR","GOLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915054","title":"Novabridge Biosciences CEO, Director Srishti Gupta Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915054?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:25","pubTimestamp":1783542307,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences CEO, director Srishti Gupta files initial beneficial ownership statementNovaBridge Biosciences filed a Form 3 naming Srishti Gupta as chief executive officer, disclosing her ini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLb3rm1Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649553169","title":"Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649553169","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649553169?lang=en_us&edition=fundamental","pubTime":"2026-07-08 07:51","pubTimestamp":1783468265,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences SVP Clinical Development Xu Cong Claire sells USD 3,991 common sharesNovaBridge Biosciences SVP, Clinical Development Xu Cong Claire reported a net reduction in ordinary share h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLSnybl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}